Similar articles

• Supreme Court boosts licensees in biotech patent battles.

  Waltz E. Waltz E. Nat Biotechnol. 2007 Mar;25(3):264-5. doi: 10.1038/nbt0307-264. Epub 2007 Mar 1. Nat Biotechnol. 2007. PMID: 17344866 No abstract available.
• Obviousness, hindsight and perspective: the impact of KSR v. Teleflex on biotech and pharmaceutical patents.

  Teitelbaum R, Cohen M. Teitelbaum R, et al. Nat Biotechnol. 2007 Oct;25(10):1105-6. doi: 10.1038/nbt1007-1105. Nat Biotechnol. 2007. PMID: 17921990 No abstract available.
• US Supreme Court applies strict limits to patents.

  Robertson D. Robertson D. Nat Biotechnol. 2002 Jul;20(7):639. doi: 10.1038/nbt0702-639a. Nat Biotechnol. 2002. PMID: 12089532 No abstract available.
• Patents, biotechnology, and hematologic pathology.

  Kettelberger DM, Gambrell P, McClung G. Kettelberger DM, et al. Hematol Pathol. 1992;6(2):99-104. Hematol Pathol. 1992. PMID: 1607346 Review. No abstract available.
• Patentability of Stem Cells in the United States.

  Fendrick SE, Zuhn DL Jr. Fendrick SE, et al. Cold Spring Harb Perspect Med. 2015 Aug 20;5(12):a020958. doi: 10.1101/cshperspect.a020958. Cold Spring Harb Perspect Med. 2015. PMID: 26292987 Free PMC article. Review.